FAQs Plus

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

The current available treatment(s) have a 95-99% success rate in curing Hepatitis C (HCV) infection.

Treatment involves a eight (8) to twelve (12) week course of Maviret or Mavyret (spelling location dependent)

This medication consists of Glecaprivar and Pibrentasvir, with the most common side effects being occasional tiredness and headaches.

Please note that NOT all countries have listed this medication as a publicly funded medication, your local health professional will be able to inform you of availability.

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

A Hepatitis C RNA test (sometimes called a PCR test), is a laboratory based test using either a large “finger prick” sample of blood or venous blood sample detecting whether the Hepatitis C virus is present in the blood stream or not. A positive test indicates the virus is present and indicates treatment is required.

RNA PCR testing is (in general terms) a quantitative test measuring viral load, or if the virus is present in the blood sample.

Ribonucleic acid (RNA) is a molecule that is present in the majority of living organisms and viruses. It is made up of nucleotides, which are ribose sugars attached to nitrogenous bases and phosphate groups.

The polymerase chain reaction (PCR) is a method widely used to make millions to billions of copies of a specific DNA sample rapidly, allowing scientists to amplify a very small sample of DNA (or a part of it) sufficiently to enable detailed study.

RNA PCR testing is, where possible, our preferred test as it involves only a single test. For this you will need to speak to your health professional or contact your local laboratory service to check on availability.

Hepatitis C, or HCV, is an inflammation of the liver caused by the hepatitis C virus. The virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness to a serious, lifelong illness including liver cirrhosis and cancer. The hepatitis C virus is a bloodborne virus and most infection occur through exposure to blood from unsafe injection practices, unsafe health care, unscreened blood transfusions, injection drug use and sexual practices that lead to exposure to blood. (World Health Organization, WHO)

HCV infection is one of the leading causes of liver disease globally. WHO estimates 58 million HCV infections worldwide, with approximately 1.5 million new HCV infections annually and 290,000 deaths annually resulting from HCV infection.

The current available treatment(s) have a 95-99% success rate in curing Hepatitis C (HCV) infection.

Treatment involves a eight (8) to twelve (12) week course of Maviret or Mavyret (spelling location dependent)

This medication consists of Glecaprivar and Pibrentasvir, with the most common side effects being occasional tiredness and headaches.

Please note that NOT all countries have listed this medication as a publicly funded medication, your local health professional will be able to inform you of availability.

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

A Hepatitis C RNA test (sometimes called a PCR test), is a laboratory based test using either a large “finger prick” sample of blood or venous blood sample detecting whether the Hepatitis C virus is present in the blood stream or not. A positive test indicates the virus is present and indicates treatment is required.

RNA PCR testing is (in general terms) a quantitative test measuring viral load, or if the virus is present in the blood sample.

Ribonucleic acid (RNA) is a molecule that is present in the majority of living organisms and viruses. It is made up of nucleotides, which are ribose sugars attached to nitrogenous bases and phosphate groups.

The polymerase chain reaction (PCR) is a method widely used to make millions to billions of copies of a specific DNA sample rapidly, allowing scientists to amplify a very small sample of DNA (or a part of it) sufficiently to enable detailed study.

RNA PCR testing is, where possible, our preferred test as it involves only a single test. For this you will need to speak to your health professional or contact your local laboratory service to check on availability.

The current available treatment(s) have a 95-99% success rate in curing Hepatitis C (HCV) infection.

Treatment involves a eight (8) to twelve (12) week course of Maviret or Mavyret (spelling location dependent)

This medication consists of Glecaprivar and Pibrentasvir, with the most common side effects being occasional tiredness and headaches.

Please note that NOT all countries have listed this medication as a publicly funded medication, your local health professional will be able to inform you of availability.

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

Hepatitis C, or HCV, is an inflammation of the liver caused by the hepatitis C virus. The virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness to a serious, lifelong illness including liver cirrhosis and cancer. The hepatitis C virus is a bloodborne virus and most infection occur through exposure to blood from unsafe injection practices, unsafe health care, unscreened blood transfusions, injection drug use and sexual practices that lead to exposure to blood. (World Health Organization, WHO)

HCV infection is one of the leading causes of liver disease globally. WHO estimates 58 million HCV infections worldwide, with approximately 1.5 million new HCV infections annually and 290,000 deaths annually resulting from HCV infection.

The current available treatment(s) have a 95-99% success rate in curing Hepatitis C (HCV) infection.

Treatment involves a eight (8) to twelve (12) week course of Maviret or Mavyret (spelling location dependent)

This medication consists of Glecaprivar and Pibrentasvir, with the most common side effects being occasional tiredness and headaches.

Please note that NOT all countries have listed this medication as a publicly funded medication, your local health professional will be able to inform you of availability.

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

Hepatitis C, or HCV, is an inflammation of the liver caused by the hepatitis C virus. The virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness to a serious, lifelong illness including liver cirrhosis and cancer. The hepatitis C virus is a bloodborne virus and most infection occur through exposure to blood from unsafe injection practices, unsafe health care, unscreened blood transfusions, injection drug use and sexual practices that lead to exposure to blood. (World Health Organization, WHO)

HCV infection is one of the leading causes of liver disease globally. WHO estimates 58 million HCV infections worldwide, with approximately 1.5 million new HCV infections annually and 290,000 deaths annually resulting from HCV infection.

The current available treatment(s) have a 95-99% success rate in curing Hepatitis C (HCV) infection.

Treatment involves a eight (8) to twelve (12) week course of Maviret or Mavyret (spelling location dependent)

This medication consists of Glecaprivar and Pibrentasvir, with the most common side effects being occasional tiredness and headaches.

Please note that NOT all countries have listed this medication as a publicly funded medication, your local health professional will be able to inform you of availability.

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

A Hepatitis C RNA test (sometimes called a PCR test), is a laboratory based test using either a large “finger prick” sample of blood or venous blood sample detecting whether the Hepatitis C virus is present in the blood stream or not. A positive test indicates the virus is present and indicates treatment is required.

RNA PCR testing is (in general terms) a quantitative test measuring viral load, or if the virus is present in the blood sample.

Ribonucleic acid (RNA) is a molecule that is present in the majority of living organisms and viruses. It is made up of nucleotides, which are ribose sugars attached to nitrogenous bases and phosphate groups.

The polymerase chain reaction (PCR) is a method widely used to make millions to billions of copies of a specific DNA sample rapidly, allowing scientists to amplify a very small sample of DNA (or a part of it) sufficiently to enable detailed study.

RNA PCR testing is, where possible, our preferred test as it involves only a single test. For this you will need to speak to your health professional or contact your local laboratory service to check on availability.

The current available treatment(s) have a 95-99% success rate in curing Hepatitis C (HCV) infection.

Treatment involves a eight (8) to twelve (12) week course of Maviret or Mavyret (spelling location dependent)

This medication consists of Glecaprivar and Pibrentasvir, with the most common side effects being occasional tiredness and headaches.

Please note that NOT all countries have listed this medication as a publicly funded medication, your local health professional will be able to inform you of availability.

Where ever possible we encourage you to visit a GP or medical facility where a RNA PCR type test can be conducted, this is the definitive single test that can lead to diagnosis and treatment. Where this is not possible, or you do not wish to engage with medical people or practice, you can use the Health Network Collective app to request an antibody Point of Care Test (POCT) by one of our community testers. That is, where the service is available. In the event your antibody POCT test is positive you will need another RNA PCR test, either finger prick or venous blood sample, to have a definitive diagnosis and get linked to treatment.

A Hepatitis C RNA test (sometimes called a PCR test), is a laboratory based test using either a large “finger prick” sample of blood or venous blood sample detecting whether the Hepatitis C virus is present in the blood stream or not. A positive test indicates the virus is present and indicates treatment is required.

RNA PCR testing is (in general terms) a quantitative test measuring viral load, or if the virus is present in the blood sample.

Ribonucleic acid (RNA) is a molecule that is present in the majority of living organisms and viruses. It is made up of nucleotides, which are ribose sugars attached to nitrogenous bases and phosphate groups.

The polymerase chain reaction (PCR) is a method widely used to make millions to billions of copies of a specific DNA sample rapidly, allowing scientists to amplify a very small sample of DNA (or a part of it) sufficiently to enable detailed study.

RNA PCR testing is, where possible, our preferred test as it involves only a single test. For this you will need to speak to your health professional or contact your local laboratory service to check on availability.